Inactive Instrument
Auspex Pharmaceuticals Inc Share Price
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 22/15/22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 22/15/22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 01/09/2009 |
Rod Ferguson
BRD | Director/Board Member | 69 | 01/01/2013 |
Alex Zisson
BRD | Director/Board Member | 56 | 17/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.83% | +2.88% | +55.87% | +69.12% | 6.94TCr | |
| -1.18% | -0.02% | +9.44% | +74.75% | 5.72TCr | |
| -1.65% | +3.01% | +24.83% | +100.24% | 5.76TCr | |
| +2.01% | +0.31% | +27.17% | +35.16% | 4.37TCr | |
| +5.10% | +9.34% | +21.83% | +106.45% | 4.4TCr | |
| +3.39% | -3.35% | +201.24% | +758.40% | 3.81TCr | |
| +7.50% | +13.58% | +29.07% | +64.46% | 3.63TCr | |
| -4.11% | -11.07% | +86.29% | +73.78% | 3.26TCr | |
| -2.18% | +7.06% | +36.06% | -4.95% | 2.55TCr | |
| Average | +0.49% | +2.49% | +54.64% | +141.93% | 4.49TCr | |
| Weighted average by Cap. | +0.10% | +2.64% | +50.56% | +134.94% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
